Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses

Vaccine

Volumn 24, Issue 9, 2006, Pages 1254-1263

  Perrin Cocon, Laure ^a   Agaugué, Sophie ^a   Coutant, Frédéric ^a   Saint Mézard, Pierre ^a   Guironnet Paquet, Aurélie ^a   Nicolas, Jean François ^a   André, Patrice ^a   Lotteau, Vincent ^a  

^a INSERM   (France)

Author keywords

Acute phase reactants; Adjuvant; Immunomodulators; Lipid Mediators; Lysophosphatidylcholine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; LYSOPHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LIPID OXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN ALLERGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; MURAMIDASE; OVALBUMIN;

EID: 32344434352     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.036     Document Type: Article

References (47)

1. H. Baumann, and J. Gauldie The acute phase response Immunol Today 15 2 1994 74 80
2. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 6 1999 448 454
3. V.G. Cabana, J.N. Siegel, and S.M. Sabesin Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins J Lipid Res 30 1 1989 39 49
4. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 34 1997 20963 20966
5. J.L. Witztum, and D. Steinberg Role of oxidized low density lipoprotein in atherogenesis J Clin Invest 88 6 1991 1785 1792
6. R.A. Memon, I. Staprans, M. Noor, W.M. Holleran, Y. Uchida, and A.H. Moser Infection and inflammation induce LDL oxidation in vivo Arterioscler Thromb Vase Biol 20 6 2000 1536 1542
7. L. Perrin-Cocon, F. Coutant, S. Agaugue, S. Deforges, P. Andre, and V. Lotteau Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte J Immunol 167 7 2001 3785 3791
8. F. Coutant, L. Perrin-Cocon, S. Agaugue, T. Delair, P. Andre, and V. Lotteau Mature dendritic cell generation promoted by lysophosphatidylcholine J Immunol 169 4 2002 1688 1695
9. F. Coutant, S. Agaugue, L. Perrin-Cocon, P. Andre, and V. Lotteau Sensing environmental lipids by dendritic cell modulates its function J Immunol 172 1 2004 54 60
10. U.P. Steinbrecher, and P.H. Pritchard Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase J Lipid Res 30 3 1989 305 315
11. K. Lauber, E. Bohn, S.M. Krober, Y.J. Xiao, S.G. Blumenthal, and R.K. Lindemann Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal Cell 113 6 2003 717 730
12. S.J. Kim, D. Gershov, X. Ma, N. Brot, and K.B. Elkon I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation J Exp Med 196 5 2002 655 665
13. M.T. Quinn, S. Parthasarathy, and D. Steinberg Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis Proc Natl Acad Sci USA 85 8 1988 2805 2809
14. K. Lauber, S.G. Blumenthal, M. Waibel, and S. Wesselborg Clearance of apoptotic cells: getting rid of the corpses Mol Cell 14 3 2004 277 287
15. H.F. McMurray, S. Parthasarathy, and D. Steinberg Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes J Clin Invest 92 2 1993 1004 1008
16. C.G. Radu, L.V. Yang, M. Riedinger, M. Au, and O.N. Witte T cell chemotaxis to lysophosphatidylcholine through the G2A receptor Proc Natl Acad Sci USA 101 1 2004 245 250
17. N. Kume, and M.A. Gimbrone Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells J Clin Invest 93 2 1994 907 911
18. T. Nakano, E.W. Raines, J.A. Abraham, M. Klagsbrun, and R. Ross Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes Proc Natl Acad Sci USA 91 3 1994 1069 1073
19. N. Kume, M.I. Cybulsky, and M.A. Gimbrone Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells J Clin Invest 90 3 1992 1138 1144
20. N. Takahara, A. Kashiwagi, H. Maegawa, and Y. Shigeta Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells Metabolism 45 5 1996 559 564
21. Q. Jing, S.M. Xin, W.B. Zhang, P. Wang, Y.W. Qin, and G. Pei Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis Circ Res 87 1 2000 52 59
22. S.S. Ousman, and S. David Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord Glia 30 1 2000 92 104
23. 2+ signaling via the platelet-activating factor receptor in macrophages Am J Physiol 272 1 Pt 2 1997 H17 H24
24. J. Oestvang, M.W. Anthonsen, and B. Johansen Role of secretory and cytosolic phospholipase A(2) enzymes in lysophosphatidylcholine-stimulated monocyte arachidonic acid release FEBS Lett 555 2 2003 257 262
25. B.Z. Ngwenya, and N. Yamamoto Activation of peritoneal macrophages by lysophosphatidylcholine Biochim Biophys Acta 839 1 1985 9 15
26. M.M. Whalen, R.N. Doshi, B.W. Bader, and A.D. Bankhurst Lysophosphatidylcholine and arachidonic acid are required in the cytotoxic response of human natural killer cells to tumor target cells Cell Physiol Biochem 9 6 1999 297 309
27. A.K. Ryborg, B. Deleuran, H. Sogaard, and K. Kragballe Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes Acta Derm Venereol 80 4 2000 242 246
28. J.J. Yan, J.S. Jung, J.E. Lee, J. Lee, S.O. Huh, and H.S. Kim Therapeutic effects of lysophosphatidylcholine in experimental sepsis Nat Med 10 2004 161 167
29. Z. Weng, A.C. Fluckiger, S. Nisitani, M.I. Wahl, L.Q. Le, and C.A. Hunter A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M Proc Natl Acad Sci USA 95 21 1998 12334 12339
30. J.H. Kabarowski, K. Zhu, L.Q. Le, O.N. Witte, and Y. Xu Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A Science 293 5530 2001 702 705
31. O.N. Witte, J.H. Kabarowski, Y. Xu, L.Q. Le, and K. Zhu Retraction Science 307 5707 2005 206b
32. B.Z. Ngwenya, and D.M. Foster Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol Proc Soc Exp Biol Med 196 1 1991 69 75
33. B. Arnold, F.G. Staber, and J.F. Miller Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. II. Studies on the mode of action Eur J Immunol 9 5 1979 367 370
34. B. Arnold, J.F. Miller, and H.U. Weltzien Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. I. Characterization of the adjuvant effect Eur J Immunol 9 5 1979 363 366
35. P. Matzinger Tolerance, danger, and the extended family Annu Rev Immunol 12 1994 991 1045
36. P. Matzinger An innate sense of danger Semin Immunol 10 5 1998 399 415
37. P. Saint-Mezard, M. Krasteva, C. Chavagnac, S. Bosset, H. Akiba, and J. Kehren Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD J Invest Dermatol 120 4 2003 641 647
38. J. Kehren, C. Desvignes, M. Krasteva, M.T. Ducluzeau, O. Assossou, and F. Horand Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity J Exp Med 189 5 1999 779 786
39. H. Akiba, J. Kehren, M.T. Ducluzeau, M. Krasteva, F. Horand, and D. Kaiserlian Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis J Immunol 168 6 2002 3079 3087
40. M.B. Ebhardt, C.L. Shive, R. Guardia, L. Gapin, B.O. Boehm, and T.G. Forsthuber Immunological adjuvants efficiently induce antigen-specific T cell responses in old mice: implications for vaccine adjuvant development in aged individuals Cell Immunol 215 1 2002 87 97
41. R.S. Chu, O.S. Targoni, A.M. Krieg, P.V. Lehmann, and C.V. Harding CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity J Exp Med 186 10 1997 1623 1631
42. K. Zhu, L.M. Baudhuin, G. Hong, F.S. Williams, K.L. Cristina, and J.H. Kabarowski Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4 J Biol Chem 276 44 2001 41325 41335
43. Y.H. Huang, L. Schafer-Elinder, R. Wu, H.E. Claesson, and J. Frostegard Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism Clin Exp Immunol 116 2 1999 326 331
44. T. Aoyama, M. Chen, H. Fujiwara, T. Masaki, and T. Sawamura LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells FEBS Lett 467 2-3 2000 217 220
45. R.K. Gupta Aluminum compounds as vaccine adjuvants Adv Drug Deliv Rev 32 3 1998 155 172
46. L. Perrin-Cocon, S. Agaugue, F. Coutant, A. Masurel, S. Bezzine, and G. Lambeau Secretory phospholipase A2 induces dendritic cell maturation Eur J Immunol 34 2004 2293 2302
47. O.W. Portman, and M. Alexander Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis J Lipid Res 10 2 1969 158 165